Complement-ARIE Challenge
Pays up to $50,000 each to 20 teams building human-based alternatives to animal testing.
The Complement-ARIE Challenge is an NIH Common Fund prize that pays up to $50,000 each to 20 teams building human-based alternatives to animal testing. Teams submitted a 15-page whitepaper covering methodology, team expertise, scientific rationale and potential impact, scored against five weighted judging criteria: understanding of the problem, feasibility, innovation, potential impact and team co…
The challenge sought New Approach Methodologies (NAMs) that model human biology without animal models: in vitro human-derived cell or tissue systems, in silico computational and AI-driven simulations, in chemico cell-free systems, and integrations across these. Submissions had to demonstrate substantial advancement over current NAM approaches and could target areas like rare disease, pregnancy, toxicology or drug response modeling.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see what you submit
Sign up free to see how they score you
Sign up free to see the timeline
Sign up free to see where teams trip up
Guides for this application
All guides →NIH Biosketch Guide: Format, SciENcv Steps, and Examples
Learn what an NIH biosketch is, how the format works, what to prepare for SciENcv, and how startup teams should avoid common biosketch mistakes.
Write proposalHow to Write a Specific Aims Page
Learn how to write a specific aims page for NIH, SBIR-adjacent, and translational R&D grants, with structure, reviewer logic, examples, and common mistakes.
Where to applyGrants for Biotech Startups: NIH, NSF, SBIR/STTR, and Non-Dilutive Funding
A practical guide to grants for biotech startups, including NIH SBIR/STTR, NSF, translational funding, evidence, regulatory readiness, and budgets.
Write proposalHow to Write a Grant Proposal Reviewers Can Score
Learn how to write a grant proposal around reviewer criteria, evidence, work packages, budget logic, and commercialization for deeptech and R&D funding.
More from NIH Common Fund
All grants from this funder →CARE for Health — Open Funding (Seed)
🇺🇸NIH Common Fund · United States
Supports integrating clinical research into primary care environments through rural-focused network models.
Complement-ARIE — Open Funding (Seed)
🇺🇸NIH Common Fund · United States
Supports development of human-based new approach methodologies replacing animal models in relevant research.
Human Virome Program — Open Funding (Seed)
🇺🇸NIH Common Fund · United States
Offers exploration of the healthy human virome and virus host interactions across translational studies.
NIH Common Fund Venture Program — Open Funding (Seed)
🇺🇸NIH Common Fund · United States
Supports high-potential short- to medium-range initiatives that can seed major breakthroughs.
Replication Initiative — Open Funding (Seed)
🇺🇸NIH Common Fund · United States
Funds independent validation of biomedical findings to strengthen reproducibility in research.
NIH Director's Early Independence Award
🇺🇸NIH Common Fund · United States
Funds a scientist to skip the postdoc entirely and run their own lab straight after the doctorate — ten awards of $350,000 each.
Similar grants
Browse the directory →
MIT Solve Global Challenges
🇺🇸MIT · United States
Supports teams tackling global challenges by selecting and backing scalable ideas through MIT Solve challenge pathways.
NOURISH: Autoimmunity Digital Health Challenge
🇺🇸OADR-ORWH · United States
Awards up to $650,000 across three phases for digital tools tracking autoimmune nutrition.
Oligonucleotide Toxicity (OligoTox) Open Data Challenge
🇺🇸NCATS · United States
Pays cash prizes for public datasets that help predict oligonucleotide drug toxicity in human cells.
NIA Start-Up Challenge
🇺🇸NIA · United States
Funds US entrepreneurs and small businesses developing healthy-aging technologies through NIA's Start-Up Challenge cash prizes and accelerator.
2025 NIA Start-Up Challenge and Accelerator
🇺🇸NIA · United States
Awards up to $75,000 and a 5-month accelerator to entrepreneurs building aging-research startups.
TRDNT Challenge Phase II: Prototype Development and Use Case Demonstration
🇺🇸NIH · United States
Pays up to $120,000 per Interim Milestone winner and up to $320,000 per Final Submission winner to US-based researchers, startups and institutions that build a working prototype technology able to target endogenous RNA in human disease.